BPC 157: Experimental Peptide Creates Risk for Athletes Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step Compounded "semaglutide" is not FDA approved semaglutide.com FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA Peptide Reclassification 2026 Amanecia Health